Sanofi Sued by Texas Attorney General Over Alleged Provider 'Bribery'

MT Newswires Live
02/20

Sanofi (SNY) has been sued by Texas Attorney General Ken Paxton over allegations that it offers improper incentives to healthcare providers to prescribe its drugs.

The Texas Attorney General's Office said Sanofi created programs that offered services to healthcare providers which amounted to bribes under the Texas Health Care Program Fraud Prevention Act.

Paxton is seeking more than $1 million in monetary relief, including civil penalties, as well as an injunction to halt any alleged unlawful conduct, the Attorney General's Office added.

Sanofi said the complaint mischaracterizes legitimate patient support programs, including nurse education and reimbursement assistance services.

The company added that the programs comply with federal and state laws.

"The state's intervention has no bearing on the merits of this case, and Sanofi is zealously defending this litigation," the drugmaker said in an emailed statement.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10